Library

Home > Library

Search results : meta

AYA analytic report on global technological developments October 2027

2027-10-01This report explains almost all aspects of the current global race toward AGI between both the U.S. and China.

Our fintech finbuzz analytic report shines light on the current global technological advancements. As of Autumn-Winter 2027, this report shines new light on almost all aspects of the current technological race between the U.S. ...+See More
AYA analytic report on global technological developments April 2027

2027-04-01This report explains why the current AI-driven stock market rally may not be an asset bubble yet.

Our fintech finbuzz analytic report shines light on the current global technological advancements. As of Spring-Summer 2027, this report describes, discusses, and delves into the new, non-obvious, and practical technological ad...+See More
AYA analytic report on global technological developments October 2026

2026-10-01This report delves into how today tech titans reshape global pharmaceutical investments for both better healthspan and longer lifespan.

Our fintech finbuzz analytic report shines light on the current global technological advancements. As of Fall-Winter 2026, this analytic report delves into the current technological advances, medications, and treatments for dis...+See More
AYA analytic report on global technological developments April 2026

2026-04-01This article delves into AI-driven new medications, treatments, therapies, and healthcare services worldwide.

Our fintech finbuzz analytic report shines light on the current global technological advancements. As of Spring-Summer 2026, we delve into the latest advances in AI healthcare, medicine, and broader biotechnology worldwide. New...+See More
Stock Synopses for the Top 20 Tech Titans (October 2025)

2025-10-15This ebook delves into the AI-driven comprehensive fundamental analysis of each of the top 20 tech titans in terms of their competitive advantages, economic moats, and technological innovations.

Our new ebook shines new light on the stock synopses for the top 20 tech titans in America. As of October 2025, we describe, discuss, and delve into the major comprehensive fundamental analysis of each of the Magnificent 7 and ...+See More
AYA analytic report on global technological developments October 2025

2025-10-01This report delves into the technological advances in the global market for GLP-1 anti-obesity weight-loss medications.

Our fintech finbuzz analytic report shines light on the current global technological advancements. As of Fall-Winter 2025, this report delves into the latest advances in medications for obesity treatment and weight loss treatme...+See More
AYA analytic report on global technological developments April 2025

2025-04-01The global cloud Internet infrastructure expands what can be digitally feasible from electric vehicles (EV) and virtual reality (VR) headsets to generative artificial intelligence (Gen AI) and the metaverse.

Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Spring-Summer 2025, this analytic report delves into the new global market for mobile cloud telecommunication. The cloud Inte...+See More
AYA analytic report on global technological developments October 2024

2024-10-02This analytic report delves into the recent technological advancements in Generative Artificial Intelligence (Gen AI).

Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Autumn-Winter 2024, this analytic report delves into the new global market for generative artificial intelligence (Gen AI). T...+See More
1

Blog+More

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects.

Laura Hermes

2023-02-07 08:26:00 Tuesday ET

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects.

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects. Michel De Vroey (2016)

+See More

U.S. trade envoy Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement.

Daisy Harvey

2019-03-17 14:35:00 Sunday ET

U.S. trade envoy Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement.

U.S. trade rep Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement. America has to maintain the thr

+See More

AYA free finbuzz analytic report on the U.S. top tech titans FAMGA Spring-Summer 2020

Chanel Holden

2020-05-05 09:31:00 Tuesday ET

AYA free finbuzz analytic report on the U.S. top tech titans FAMGA Spring-Summer 2020

Our fintech finbuzz analytic report shines fresh light on the fundamental prospects of U.S. tech titans Facebook, Apple, Microsoft, Google, and Amazon (F.A.

+See More

Nobel Laureate Joseph Stiglitz proposes the primary economic priorities in lieu of neoliberalism.

Fiona Sydney

2019-06-29 17:30:00 Saturday ET

Nobel Laureate Joseph Stiglitz proposes the primary economic priorities in lieu of neoliberalism.

Nobel Laureate Joseph Stiglitz proposes the primary economic priorities in lieu of neoliberalism. Neoliberalism includes lower taxation, deregulation, socia

+See More

Millennials can save to make a fortune with compound interest over 40 years.

Laura Hermes

2017-07-25 10:44:00 Tuesday ET

Millennials can save to make a fortune with compound interest over 40 years.

NerdWallet's new simulation suggests that a 25-year-old millennial who earns an inflation-free base salary of $40,456 and saves 15% each year faces a 99

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More